Abstract
Background and aim
Metabolic dysfunctions, particularly hyperlipidemia, are a common finding in Primary
Biliary Cholangitis (PBC). In presence of metabolic components of fatty-liver-disease
(MAFLD), the liver fibrosis progression risk is higher. The aim of this study was
to evaluate lifestyle of PBC patients compared to controls.
Methods
In a prospective, multicenter study 107 PBC patients were enrolled; among these, 54
subjects were age-and sex-matched with 54 controls with a propensity-score-matching-analysis.
Eating habits and physical activity were evaluated, respectively, with a food-frequency-questionnaire
and with a short pre-validated-questionnaire. The adherence to Mediterranean diet
was assessed with the alternate Mediterranean diet score.
Results
The total fat intake was higher in controls than in PBC (p=0.004), unless above the national recommendations in both groups. Moreover, in PBC
monounsaturated-fat and polyunsaturated-fatty-acid intakes and the adherence to Mediterranean
diet were significantly lower than in controls (p<0.001, p=0.005 and p<0.001 respectively). Regarding physical activity, PBC subjects had a sedentary behavior
as well as controls.
Conclusions
The lifestyle of both PBC and controls is at high risk of developing MAFLD. Therefore,
hepatologists should regularly evaluate eating habits and physical activity in PBC
patients and promote a lifestyle change to reduce liver disease progression risk.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Digestive and Liver DiseaseAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- EASL clinical practice guidelines. The diagnosis and management of patients with primary biliary cholangitis.J Hepatol. 2017; 67: 145-172
- Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid.Gastroenterology. 2013; 144: 560-569
- The pathogenesis of primary biliary cholangitis: a comprehensive review.Semin Liver Dis. 2020; 40: 34-48
- Primary biliary cholangitis: pathogenesis and therapeutic opportunities.Nat Rev Gastroenterol Hepatol. 2020; 17: 93-110
- Diagnosis and management of primary biliary cirrhosis.Expert Rev Clin Immunol. 2014; 10: 1667-1678
- Primary biliary cirrhosis.Lancet. 2015; 386: 1565-1575
- Milder disease stage in patients with primary biliary cholangitis over a 44-year period: a changing natural history.Hepatology. 2018; 67: 1920-1930
- Hypercholesterolemia in primary biliary cirrhosis.N Engl J Med. 2007; 357: 1561-1562
- Hyperlipidaemia in primary biliary cholangitis: treatment, safety and efficacy.Frontl Gastroenterol. 2019; 10: 401-408
- Hypercholesterolemia is not associated with early atherosclerotic lesions in primary biliary cirrhosis.Gut. 2006; 55: 1795-1800
- Plasma adiponectin levels in primary biliary cirrhosis: a novel perspective for link between hypercholesterolemia and protection against atherosclerosis.Am J Gastroenterol. 2008; 103: 1959-1965
- Patterns of serum lipids derangements and cardiovascular risk assessment in patients with primary biliary cholangitis.Ann Hepatol. 2019; 18: 879-882
- Primary biliary cirrhosis is more severe in overweight patients.J Clin Gastroenterol. 2013; 47: e28-e32
- Quality criteria for the measurement of liver stiffness.Clin Res Hepatol Gastroenterol. Jan 2022; 46101761
- Liver steatosis assessed by controlled attenuation parameter (cap) measured with the xl probe of the fibroscan: a pilot study assessing diagnostic accuracy.Ultrasound Med Biol. Jan 2016; 42: 92-103
- Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis.J Hepatol. 2022 Jun 28; (S0168-8278(22)00411-1)
- The update of the Italian food composition database.J Food Compos Anal. 2004; 17: 509e22
- Diet and overall survival in elderly people.BMJ. 1995; 311: 1457e60
- Evaluating and adapting the Mediterranean diet for non-Mediterranean populations: a critical appraisal.Nutr Rev. 2013; 71: 573e84
AAVV. Gruppo di esperti costituito presso l'Istituto Nazionale di Ricerca per gli Alimenti e la Nutrizione (INRAN). Linee guida per una sana alimentazione italiana. Ministero delle Politiche Agricole e Forestali e INRAN. 2003. https://www.fao.org/3/as686o/as686o.pdf. Accessed June 5, 2022.
- International physical activity questionnaire: 12-country reliability and validity.Med Sci Sports Exerc. 2003; 35: 1381-1395
- European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO). EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease.J Hepatol. Jun 2016; 64: 1388-1402
- IV Revisione dei Livelli di Assunzione di Riferimento di Nutrienti ed energia per la popolazione italiana.Società Italiana di Nutrizione Umana (SINU), 2014 (Accessed June 5, 2022)
- 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American college of cardiology/American heart association task force on practice guidelines and the obesity society.J Am Coll Cardiol. 2014; 63: 2985-3023
- The hypertriglyceridemic-waist phenotype as a valuable and integrative mirror of metabolic syndrome traits.Sci Rep. 2021 Nov 8; 11: 21859
- Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study.Hepatology. 2005; 42: 44-52
- Waist circumference and waist/hip ratio in relation to all-cause mortality, cancer and sleep apnea.Eur J Clin Nutr. Jan 2010; 64: 35-41
- Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression.Hepatology. 2003; 38: 1529-1539
- Dietary n-3 polyunsaturated fatty acids decrease hepatic triglycerides in Fischer 344 rats.Hepatology. 2004; 39: 608-616
- Overfeeding polyunsaturated and saturated fat causes distinct effects on liver and visceral fat accumulation in humans.Diabetes. 2014; 63: 2356-2368
- Effects of n-6 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: a randomized controlled trial.Am J Clin Nutr. 2012; 95: 1003-1012
- Consumption of n-3 fatty acids and fish reduces risk of hepatocellular carcinoma.Gastroenterology. 2012; 142: 1468-1475
- Association between dietary nutrient composition and the incidence of cirrhosis or liver cancer in the United States population.Hepatology. 2009; 50: 175-184
- Definition of the Mediterranean diet; a literature review.Nutrients. 2015; 7: 9139-9153
- Mediterranean diet and cardiovascular risk factors: a systematic review.Crit Rev Food Sci Nutr. 2014; 54: 593-610
- Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts.N Engl J Med. 2018; 378: e34
- Prevention of diabetes with Mediterranean diets: a subgroup analysis of a randomized trial.Ann Intern Med. 2014; 160: 1-10
- The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease.J Hepatol. 2013; 59: 138-143
- Television viewing behaviour and associations with food habits in different countries.Public Health Nutr. 2006; 9: 244-250
- Television viewing and risk of type 2 diabetes, cardiovascular disease, and all-cause mortality: a meta-analysis.JAMA. 2011 Jun 15; 305: 2448-2455
- Effect of aerobic exercise training dose on liver fat and visceral adiposity.J Hepatol. 2015; 63: 174-182
- Dissociation between exercise-induced reduction in liver fat and changes in hepatic and peripheral glucose homoeostasis in obese patients with non-alcoholic fatty liver disease.Clin Sci (Lond). 2016; 130: 93-104
- Exercise training reduces liver fat and increases rates of VLDL clearance but not VLDL production in NAFLD.J Clin Endocrinol Metab. 2016; 101: 4219-4228
- Visceral fat: a key mediator of steatohepatitis in metabolic liver disease.Hepatology. 2008; 48: 449-457
- Liver transplant-free survival according to alkaline phosphatase and GLOBE score in patients with primary biliary cholangitis treated with ursodeoxycholic acid.Aliment Pharmacol Ther. Nov 2022; 56: 1408-1418
- Incidence and risk factors for hepatocellular carcinoma in primary biliary cirrhosis.Clin Rev Allergy Immunol. Jun 2015; 48: 132-141
- Current trends and characteristics of hepatocellular carcinoma in patients with autoimmune liver diseases.Cancers (Basel). 2021; 13: 1023
Article info
Publication history
Published online: December 31, 2022
Accepted:
December 8,
2022
Received:
June 19,
2022
Publication stage
In Press Corrected ProofIdentification
Copyright
© 2022 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
